Regenerative Medical Technology Group Inc. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Regenerative Medical Technology Group Inc. stock issued during period, value, new issues for the quarter ending 2025-06-30 was $401.00.
- Regenerative Medical Technology Group Inc. stock issued during period, value, new issues for the quarter ending 2021-12-31 was $0.00.
- Regenerative Medical Technology Group Inc. stock issued during period, value, new issues for the quarter ending 2021-09-30 was $5.04M.
- Regenerative Medical Technology Group Inc. stock issued during period, value, new issues for the quarter ending 2021-03-31 was $1.07M.
- Regenerative Medical Technology Group Inc. stock issued during period, value, new issues for fiscal 2022 was $251.54K, a 95.01% decline from fiscal 2021.
- Regenerative Medical Technology Group Inc. stock issued during period, value, new issues for fiscal 2021 was $5.04M, a 368.73% increase from fiscal 2020.
- Regenerative Medical Technology Group Inc. stock issued during period, value, new issues for fiscal 2020 was $1.07M, a 0.00% change from fiscal 2019.
- Regenerative Medical Technology Group Inc. stock issued during period, value, new issues for fiscal 2019 was $1.07M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2025-06-30 | $401.00 10-Q · filed 2026-08-19 | |
| 2022-12-31 | $251.54K 10-K · filed 2024-04-15 | |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-14 | $5.04M 10-K · filed 2023-04-14 |
| 2021-09-30 | $5.04M 10-Q · filed 2022-11-09 | |
| 2021-03-31 | $1.07M 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-04-13 | $1.07M 10-K · filed 2021-04-13 |
| 2019-12-31 | $1.07M 10-K · filed 2022-05-05 |